Skip to content
Search

Latest Stories

Google Pixel 10: 7 things the latest leak revealed about the phone

The phone was reportedly being filmed for a TV advert

Google Pixel 10 leak revealed

The Pixel 10 appears to maintain the camera design introduced in previous models

Getty

Leaks surrounding the upcoming Google Pixel 10 have started surfacing, offering a first look at the tech giant’s next flagship device. Spotted on a public beach in Vancouver, Canada, the phone was reportedly being filmed for a TV advert, giving passers-by an unexpected preview. From design changes to new features and colour options, here are seven key things we’ve learnt from the leak.

1. Pixel 10 caught on camera during filming
The Pixel 10 Pro (or possibly the Pixel 10 Pro XL) was seen in public during what appeared to be a promotional shoot for Google. A video production crew was spotted working on a beach, where a bystander was able to view the phone and even the storyboard for the shoot — a rare, unguarded glimpse into Google’s plans.


2. New AI-powered camera feature: ‘Google Add Me’
The storyboard revealed an upcoming feature called Google Add Me, an AI tool designed to enhance group photography. The feature will allow users to add people to the same photo after it’s taken, such as including the photographer in the final image. This builds on Google's continued use of AI in the Pixel’s camera software.

3. Refined camera design continues
The Pixel 10 appears to maintain the camera design introduced in previous models, a horizontal camera bar with a black oval housing the sensors. However, the leaked phone shows a slightly larger protruding oval with additional space, presumably for the LED flash, suggesting some refinement in the hardware layout.

4. Colour options revealed
New colour variants were also uncovered in the leak. The Pixel 10 will reportedly come in:

  • Obsidian (Black)
  • Blue
  • Iris (Purple)
  • Limoncello (likely Yellow)

Meanwhile, the Pixel 10 Pro and Pro XL models are expected in:

  • Obsidian
  • Green
  • Sterling (Grey)
  • Porcelain (White)

5. Blue model spotted in the wild
The device seen on the Vancouver beach appeared to be the Blue version of the Pixel 10, indicating Google will lean into bolder colours this time around. This adds visual variety compared to the typically muted palette of previous Pixel phones.

6. Possible multiple Pro models
The leak mentions both Pixel 10 Pro and Pixel 10 Pro XL, suggesting Google may release two larger flagship models. If true, this would mark a return to the XL naming convention, which had been previously dropped in favour of the regular and Pro distinction.

7. Expected launch in August
While the Pixel line traditionally launched in October, Google moved up the release of the Pixel 9 series to mid-August 2024. Based on the filming timeline and consistent patterns, it’s likely the Pixel 10 series will also launch around August 2025, maintaining this revised schedule.

With a mix of AI-powered features, new colours, and potential model variants, the Pixel 10 is shaping up to be one of Google’s most anticipated releases. The official launch is expected within the next few months.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less